NCT04363307View on ClinicalTrials.gov

Prospective Study to Validate Ablation Parameters with MRI Based Scar for Left Atrial Ablation

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

May 14, 2020

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Atrial Fibrillation
Interventions
DEVICE

AF Ablation

Adult participants undergoing standard of care AF ablation using VISITAG SURPOINT

DEVICE

MRI

Adult participants will undergo a late gadolinium enhancement MRI of the left atrium three months post standard of care ablation

Trial Locations (1)

84132

University of Utah Health Sciences Center, Salt Lake City

All Listed Sponsors
collaborator

Biosense Webster, Inc.

INDUSTRY

lead

Ravi Ranjan

OTHER

NCT04363307 - Prospective Study to Validate Ablation Parameters with MRI Based Scar for Left Atrial Ablation | Biotech Hunter | Biotech Hunter